CN106361733A - External application meridian acupoint agonist - Google Patents

External application meridian acupoint agonist Download PDF

Info

Publication number
CN106361733A
CN106361733A CN201510431837.6A CN201510431837A CN106361733A CN 106361733 A CN106361733 A CN 106361733A CN 201510431837 A CN201510431837 A CN 201510431837A CN 106361733 A CN106361733 A CN 106361733A
Authority
CN
China
Prior art keywords
acupuncture
agonist
external application
point
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510431837.6A
Other languages
Chinese (zh)
Inventor
刘里远
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510431837.6A priority Critical patent/CN106361733A/en
Publication of CN106361733A publication Critical patent/CN106361733A/en
Pending legal-status Critical Current

Links

Abstract

The invention provides a new drug use formula, and relates to an external application meridian acupoint agonist, which comprises a main component such as a sympathetic nerve alpha receptor stimulant, wherein the components in the formula comprise 300-1000 mg/L of norepinephrine, 200-600 mg/L of epinephrine, 100-300 ml/L of azone(N-laurylazacycloheptan-2-one), 100-200 ml/L of alkylphenol polyoxyethylene ether (OP-10), and 100-300 ml/L of ethanol. According to the present invention, the mixture is a colorless and transparent viscous liquid; during the use, the drug is coated on the acupoints, such that the strong acupuncture effect can be produced in the simulated manner so as to replace the acupuncture and treat the disease; and the external application meridian acupoint agonist has advantages of no pain, no side effect, convenience, low cheap, and high efficiency.

Description

External is through cave agonist
Technical field
The present invention relates to a kind of new application of medicine substitutes the pharmaceutical formulation of acupuncture, by known innerlich anwenden thing sympathetic nerve α Receptor agonist noradrenalin, epinephrine etc., are combined with transdermal agent, and directly point is applied on the acupuncture point of skin, produces The effect of similar acupuncture effect, thus substituting acupuncture, plays the more powerful but very simple clinical efficacy than acupuncture.
Background technology
The acupuncture of Chinese medicine is confirmed to treat more than 100 kind of disease by WHO, is referred to as Chinese traditional culture Rarity and Traditional Chinese Science the invention of great significance.However, most patients have fear to acupuncture pain, non-have no alternative but, Do not take into account that acupuncture and moxibustion treatment.External insturment for acupuncture and moxibustion has magnetic needle, acusector etc., but actual effect is unsatisfactory.We think always, In disease early stage, the early stage of particularly anxious severe disease, acupuncture and moxibustion treatment is used in combination, can substantially mitigate the state of an illness, promote recovery from illness.But Under present case, emergency and severe disease is all western medical treatment, and little patient does not usually go to treat.General only pass through various failing to respond to any medical treatment Chronic, just attempts department of acupuncture and moxibustion and has a try.Due to missing the best opportunity, the effect of acupuncture and moxibustion therapy is often very limited.This two Big factor limits the extensive application of therapeutic effect of acupuncture significantly and curative effect plays.
Inventor thinks always, if the method that can use modern science, gets the essence of meridians clear, is not only the weight to life sciences Contribute, and may be without acupuncture treatment, only need to be with a little medicine it is possible to simulate acupuncture, the more preferable effect of producing ratio acupuncture, Realize the modern medicine of traditional medicine.Inventor, in the vicennial time, carries out the essence of channels and collaterals and acupuncture effect always The basic research of mechanism, with going deep into step by step and breaking through, finally opens the essence of channels and collaterals.In skin under cover one unknown Cyclic system, the hair follicle arrectores pilorum on circuit is dispersed with the SNE of highly dense, uses macro-autoradiography technology It is observed that the sympathetic material distributing line of rule.Shaving off the rat of hair, newborn hair is first in these sympathetic material distributing lines On grow out, form newborn hair line loop.It is observed that Acupuncture Signals transmit along sympathetic material distributing line after acupuncture, shape Become the piloerection line of motion.Cut-out transdermal routes, medicine resistance block transdermal routes α receptor etc., both transmission of disabling signal, also block pin Thorn effect.Acupoint injection therapy α receptor agonist then can be simulated and be produced powerful acupuncture effect.Then, inventor determines to manage this Push clinical practice by research to.
Content of the invention
The invention aims to found a kind of painless have no side effect replacement acupuncture inexpensive drugs, solve minor illness oneself control, The short-cut method that severe disease early stage is controlled, allows patient's the controlling of formula it is possible to self applies acupuncture in the case of knowing a few acupuncture point Treat, or by doctor's auxiliary treatment.Therefore, this can be described as a kind of medicine of liquid acupuncture and moxibustion treatment.
The technical solution adopted for the present invention to solve the technical problems is: pharmaceutical formulation includes noradrenalin 300-1000 Mg/l, epinephrine 200-600mg/l, azone (n- lauryl azacycloheptan-2-one) 100-300ml/l, alkyl phenol polyoxy Vinyl Ether (op-10) 100-200ml/l, ethanol 100-300ml/l.Wherein, azone is transdermal agent, and op-10 is emulsifying agent, Ethanol Main Function is solvent.Add water and be configured to colourless hyalomucoid.During use, drug solution point is coated on acupuncture point, static About rest about half an hour.
The invention has the beneficial effects as follows: on a slight medicine o'clock a to acupuncture point or several acupuncture point it is possible to produce not damaged, Painless acupuncture effect, reaches the remarkable result for the treatment of disease.Simply, cheap, safe efficient.
Specific embodiment
Prescription drug is kept in Dark Place from the active compound obtaining the approval of national medicine inspection office and pharmaceutical auxiliaries, the medicine preparing.
During use, gently extrude one or several, point is coated on acupuncture point.Connected valleys, tsu san li, Baihui, pass this four big acupuncture point first, Whole body under the overall leadership, using one of them, just has positive effect, if four caves are used entirely, effect is powerful.In addition it is also possible to point exists On other acupuncture points.1-2 time on the one, 5~10 days be a course for the treatment of.After point, preferably quiet rest is more than half an hour, it is to avoid carry out strong Activity.Note: without smoothening, without massage, make medicinal liquid be gathered in acupuncture point portion, the high concentration maintaining local is with for a long time as far as possible Effect.Bilateral acupuncture point can be put, every 1-3 hour is once when seriously ill.Generally unilateral.
The treatable disease of all acupuncture is all effective, and more much better than than acupuncture effect.Including various Acute or chronic pain diseases, respectively Plant active chronic inflammation, various autonomic imbalance disease, various traumatic injury and chronic muscular strain, hemiplegia, fatigue, god Through weak, unhappy, insomnia, myopia, sexual disorder, facial wrinkles and pigmented spots etc..
Commonly encountered diseases usage: connected valleys and Baihui cure mainly Head And Face and upper limb disorder, headache point connected valleys and Baihui.Tsu san li and pass Unit cures mainly thorax abdomen and lower-limb ailments, stomachache point tsu san li and Guan Yuan, and thoracopathy can be added some points Danzhong and big vertebra.Pelvic cavity disease Disease such as gynaecopathia can put pass unit, tsu san li and sp 6.In addition, where ill, can directly put on the skin of corresponding site, Such as migraine is so that it may directly point is at temple.Health care and subhealth state are adjusted, sleeps front daily or see reconnaissance four during TV One of big acupuncture point.Hemiplegia loses no time after falling ill one week to use, and can obtain good effect.Other diseases such as flu, headache, stomachache, mistake Sleep etc., more early better.Strong suggestion inpatient uses simultaneously, and collaborative hospitalize can greatly speed up agglutination.

Claims (6)

1. a kind of new medicine use formula, through cave agonist, Main Ingredients and Appearance is sympathetic nerve α receptor agonist for entitled external.
2. medicine according to claim 1, its formula is: noradrenalin 300-1000mg/l, epinephrine 200-600 Mg/l, azone (n- lauryl azacycloheptan-2-one) 100-300ml/l, alkylphenol polyoxyethylene (op-10) 100-200 Ml/l, ethanol 100-300ml/l.
3. medicine according to claim 1, is water white transparency mucus.
4. medicine according to claim 1, external point is applied on acupuncture point, and there are connected valleys, tsu san li, Baihui, Guan Yuan in main acupuncture point.
5. medicine according to claim 1, for substituting acupuncture, simulates acupuncture effect, treats disease.
6. medicine according to claim 1, referred to as liquid acupuncture.
CN201510431837.6A 2015-07-22 2015-07-22 External application meridian acupoint agonist Pending CN106361733A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510431837.6A CN106361733A (en) 2015-07-22 2015-07-22 External application meridian acupoint agonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510431837.6A CN106361733A (en) 2015-07-22 2015-07-22 External application meridian acupoint agonist

Publications (1)

Publication Number Publication Date
CN106361733A true CN106361733A (en) 2017-02-01

Family

ID=57880402

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510431837.6A Pending CN106361733A (en) 2015-07-22 2015-07-22 External application meridian acupoint agonist

Country Status (1)

Country Link
CN (1) CN106361733A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102711471A (en) * 2009-10-26 2012-10-03 戈德玛制药股份公司 Methods of treating or preventing acute erythema

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102711471A (en) * 2009-10-26 2012-10-03 戈德玛制药股份公司 Methods of treating or preventing acute erythema

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
傅超美主编: "《中药药剂学》", 31 August 2014, 中国医药科技出版社 *
刘里远等: "交感神经敏感线与经络实质", 《中国针灸》 *

Similar Documents

Publication Publication Date Title
Gach Acupressure's potent points: a guide to self-care for common ailments
Jayasuriya Clinical acupuncture A to Z
CN104800430A (en) Essential oil for improving depth of sleep
CN107242971A (en) Ring of calming the nerves for treating insomnia
RU2127584C1 (en) Ointment exhibiting antiinflammatory, analgetic and wound-healing effects (variants)
CN201542976U (en) Novel black plaster with acupuncture point therapeutic function
Mahlovanyy et al. Bases of physical rehabilitation in medicine
CN106361733A (en) External application meridian acupoint agonist
RU2576084C1 (en) Method for prevention and elimination of changes in skin caused by aging
CN1256965C (en) Perfume back-acupoint massage health-care method for stimulating blood circulation and causing muscles and joints to relax
CN207837858U (en) A kind of tranquilizing the mind ring for treating insomnia
CN1772128A (en) Recipe of medicine for massage to relax muscles and joints and to defoxicate
Boensch Stimulation-produced analgesia: TENS, acupuncture and alternative techniques
Ai et al. Therapeutic observation of cranial suture acupuncture in treating depression
CN102204966B (en) Traditional Chinese medicine liniment for external use for relaxing muscles and tendons and alleviating pain
RU2576083C1 (en) Method of increasing efficiency of cosmetic skin care procedures
CN219835854U (en) Pressing needle for medical plaster
RU2748452C1 (en) Method for comprehensive rehabilitation of patients after new coronavirus infection (covid-19)
JP3138031U (en) Health appliances
CN102579978B (en) External traditional Chinese medicine composition for treating scapulohumeral periarthritis
CN102416157B (en) Acupoint patch prepared from Chinese medicines, and preparation method for acupoint patch
Dharmananda et al. Synopsis of scalp acupuncture
Guo et al. Commentary on Deqi and Qizhi in Acupuncture and Moxibustion Treatment.
KR20200070684A (en) A medicated plaster
Cadolino Massage therapy and cardiovascular disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170201

RJ01 Rejection of invention patent application after publication